Our Shield™ blood test gains FDA approval, ushering in a new era of colorectal cancer screening.  More Details

Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response